Plant Extracts - Economics
Research News and Information

Sunday, November 22, 2009

Willingness to pay for a treatment for pain in multiple sclerosis.

30 Dec 2008 BACKGROUND: Multiple sclerosis (MS) is a chronic neurological disease that affects 240 per 100 000 Canadians. Of these patients, 10-80% (average 70%) experience pain. Sativex is a cannabis-based drug recently approved for neuropathic pain. ... Read more...

[Economic evaluation of medical treatment of benign prostatic hyperplasia (BPH) in the specialised care setting in Spain. Application to the cost-effectiveness of two drugs frequently used in its treatment]

29 Sep 2008 OBJECTIVES: To develop a pharmacoeconomic study in order to know the average cost of BPH diagnosis and follow-up in Spain in the Urology Department setting from the perspective of the public health system, considering two frequently used drugs in ... Read more...

Selection of bioavailability markers for herbal extracts based on in silico descriptors and their correlation to in vitro permeability.

14 May 2008 Bioavailability data for herbal supplements in humans is not readily available or is difficult to obtain, because of the complexity of the composition and the diversity of the constituents. Potency of an herbal extract is due to the synergistic ... Read more...

Latest indexed articles for 'Plant Extracts - Economics'

These are the very latest articles for this heading:

• From Amrita to substance D: psychopharmacology, political economy, and technologies of the self. 27 Feb 2009
• Ginkgo might not be a brain saver. 27 Feb 2009
• Willingness to pay for a treatment for pain in multiple sclerosis. 30 Dec 2008
• [Economic evaluation of medical treatment of benign prostatic hyperplasia (BPH) in the specialised care setting in Spain. Application to the cost-effectiveness of two drugs frequently used in its treatment] 29 Sep 2008
• Selection of bioavailability markers for herbal extracts based on in silico descriptors and their correlation to in vitro permeability. 14 May 2008
• Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. 29 Apr 2008
• Plant molecular farming: opportunities and challenges. 30 Dec 2007
• Ensuring sustained ACT production and reliable artemisinin supply. 13 Sep 2007
• Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. 5 Sep 2007
• A cost-effectiveness analysis of immunotherapy with SQ allergen extract for patients with seasonal allergic rhinoconjunctivitis in selected European countries. 29 Apr 2007
• [St. John's wort extract in treatment of moderately severe depression] 30 Mar 2007
• The long-term outcome of medical therapy for BPH. 26 Mar 2007
• How green is ethanol? 13 Mar 2006
• [Crataegus special extract WS 1442 in the treatment of early stages of CHD-associated heart failure] 7 Feb 2006
• St John's wort-associated drug interactions: short-term inhibition and long-term induction? 29 Jun 2005
• [Effectiveness of echinacin in therapy of chronic recurrent respiratory disease] 30 Mar 2005
• A modified, economic, sensitive method for measuring total antioxidant capacities of human plasma and natural compounds using Indian saffron (Crocus sativus). 30 Jan 2005
• Standardization of marketed Kumariasava--an Ayurvedic Aloe vera product. 11 Jan 2005
• Enzyme recovery and recycling following hydrolysis of ammonia fiber explosion-treated corn stover. 30 Dec 2004
• [In moderate depression. St. John's wort maintains effectiveness] 3 Aug 2004

See a longer list of these articles.

Technical information about 'Plant Extracts'

Definition: Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.

Registry Number: 0

Descriptor UI: D010936

Alternative terms: Plant Extracts; Extracts, Plant;

Related Mesh Headings: Phytotherapy;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D20.215.784.500; D26.667;

History Note: 76(67); was see under PLANTS 1975

Technical Notes: coordinate with specific plant and PLANT COMPONENTS term; for use in therapy coordinate IM or NIM with phytotherapy (IM) + disease/drug ther (IM) + specific chemical / ther use (IM) if pertinent; Manual 26.29; extracts of medicinal plants in Chinese medicine = PLANT EXTRACTS, CHINESE see DRUGS, CHINESE HERBAL